Division of Urology, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
J Urol. 2019 Nov;202(5):1001-1007. doi: 10.1097/JU.0000000000000341. Epub 2019 Oct 9.
The choice of urinary diversion at cystectomy is a life altering decision. Patient decision aids are clinical tools that promote shared decision making by providing information about management options and helping patients communicate their values. We sought to develop and evaluate a patient decision aid for individuals undergoing cystectomy with urinary diversion.
We used the IPDAS (International Patient Decision Aids Standards) to guide a systematic development process. A literature review was performed to determine urinary diversion options and the incidence of outcomes. We created a prototype using the Ottawa Decision Support Framework. A 10-question survey was used to assess patient decision aid acceptability among patients, allied health professionals and urologists. The primary outcome was acceptability of the patient decision aid.
Ileal conduit and orthotopic neobladder were included as primary urinary diversion options because they had the most evidence and are most commonly performed. Continent cutaneous diversion was identified as an alternative option. Outcomes specific to ileal conduit were stomal stenosis and parastomal hernia. Outcomes specific to neobladder were daytime and nighttime urinary incontinence and urinary retention. Acceptability testing was completed by 8 urologists, 9 patients and 1 advanced practice nurse. Of the respondents 94% reported that the language was appropriate, 94% reported that the length was adequate and 83% reported that option presentation was balanced. The patient decision aid met all 6 IPDAS defining criteria, all 6 certification criteria and 21 of 23 quality criteria.
We created a novel patient decision aid to improve the quality of decisions made by patients when deciding among urinary diversion options. Effectiveness testing will be performed prospectively.
在膀胱癌根治术中选择尿路改道是一个改变生活的决定。患者决策辅助工具是临床工具,通过提供管理方案的信息并帮助患者交流其价值观,促进共同决策。我们旨在为接受膀胱癌根治术并进行尿路改道的患者开发和评估一种患者决策辅助工具。
我们使用 IPDAS(国际患者决策辅助工具标准)来指导系统的开发过程。进行文献回顾以确定尿路改道的选择和结果的发生率。我们使用渥太华决策支持框架创建了一个原型。使用包含 10 个问题的调查问卷评估患者、医疗保健专业人员和泌尿科医生对患者决策辅助工具的可接受性。主要结果是患者决策辅助工具的可接受性。
回肠导管和原位新膀胱被纳入主要的尿路改道选择,因为它们具有最多的证据并且最常进行。可控性皮管被确定为替代选择。与回肠导管相关的特定结果是造口狭窄和造口旁疝。与新膀胱相关的特定结果是白天和夜间尿失禁和尿潴留。8 名泌尿科医生、9 名患者和 1 名高级实践护士完成了可接受性测试。94%的受访者报告语言合适,94%报告长度足够,83%报告选项呈现平衡。患者决策辅助工具符合 IPDAS 定义的所有 6 个标准、所有 6 个认证标准和 23 个质量标准中的 21 个。
我们创建了一种新颖的患者决策辅助工具,以提高患者在尿路改道选择时做出决策的质量。将进行前瞻性的有效性测试。